Grace Therapeutics, Inc 10-Q for FY2023 Q3
Grace Therapeutics, Inc. (GRCE)
10-Q
2023-02-14
For: 2022-12-31
View Original
Added on
April 11, 2026
About this 10-Q
Grace Therapeutics, Inc filed this 10-Q on February 14, 2023, covering the quarter ended December 31, 2022 (FY2023 Q3).
Headline figures
Quarter ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $3.89M
- compared with a net loss of $3.78M a year earlier
- Diluted EPS
- -$0.09
- compared with -$0.09 a year earlier